𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia

✍ Scribed by Waidner, T. ;Franzen, D. ;Voelker, W. ;Ritter, M. ;Borberg, H. ;Hombach, V. ;H�pp, H.W. ;,


Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
592 KB
Volume
72
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Long-term effects of LDL apheresis in pa
✍ Bruce S. Sachais; Julie Katz; Joyce Ross; Daniel J. Rader 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism involving mutations in the LDL receptor (LDL-R). Patients with mutation in one (heterozygous) or both (homozygous) genes have markedly elevated LDL cholesterol and are at increased risk for coronary heart disease (

Improvement of endothelium-dependent cor
✍ Keiichi Igarashi; Masahiro Tsuji; Masaharu Nishimura; Masashi Horimoto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract The purpose of this study was to determine whether a single LDL apheresis would improve impaired endothelium‐dependent dilation of the coronary artery in patients with hypercholesterolemia. Hypercholesterolemia is associated with impaired endothelial function, and human studies using ch

Natriuretic peptide Val7Met substitution
✍ George V.Z. Dedoussis; Sandy Maumus; John Skoumas; Despoina M. Choumerianou; Chr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Atrial natriuretic peptide (ANP or NPPA) is the precursor protein of the form of amyloidosis called isolated atrial amyloid (IAA), which is related to the increased incidence of cardiac pathological conditions with age. Familial hypercholesterolemia (FH) patients are characterized by high concentrat

Effects of LDL-immunoapheresis on plasma
✍ Edmund Cauza; Martin Jansen; Ulrike Resch; Attila Dunky; Kurt Derfler; Brigitte 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract Recently very potent extracorporeal cholesterol‐lowering treatment options have become available for patients with hypercholesterolemia. LDL immunoapheresis treatment selectively removes LDL and lipoprotein(a) from the circulation. Since LDL is the major carrier of lipophilic antioxidan